Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

T Suda, N Takahashi, N Udagawa, E Jimi… - Endocrine …, 1999 - academic.oup.com
OSTEOCLASTS, which are present only in bone, are multinucleated giant cells with the
capacity to resorb mineralized tissues. During the past decade, several new approaches …

Paracrine and endocrine actions of bone—the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts

Y Han, X You, W **ng, Z Zhang, W Zou - Bone research, 2018 - nature.com
The skeleton is a dynamic organ that is constantly remodeled. Proteins secreted from bone
cells, namely osteoblasts, osteocytes, and osteoclasts exert regulation on …

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

P Ducy, M Amling, S Takeda, M Priemel, AF Schilling… - Cell, 2000 - cell.com
Gonadal failure induces bone loss while obesity prevents it. This raises the possibility that
bone mass, body weight, and gonadal function are regulated by common pathways. To test …

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption

LC Hofbauer, S Khosla, CR Dunstan… - Journal of bone and …, 2000 - Wiley Online Library
Although multiple hormones and cytokines regulate various aspects of osteoclast formation,
the final two effectors are osteoprotegerin ligand (OPG‐L)/osteoclast differentiation factor …

Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease

AE Kearns, S Khosla, PJ Kostenuik - Endocrine reviews, 2008 - academic.oup.com
Osteoclasts and osteoblasts dictate skeletal mass, structure, and strength via their respective
roles in resorbing and forming bone. Bone remodeling is a spatially coordinated lifelong …

Osteoclasts: new insights

F Xu, SL Teitelbaum - Bone research, 2013 - nature.com
Osteoclasts, the bone-resorbing cells, play a pivotal role in skeletal development and adult
bone remodeling. They also participate in the pathogenesis of various bone disorders …

Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine …

LC Hofbauer, F Gori, BL Riggs, DL Lacey… - …, 1999 - academic.oup.com
Osteoporosis is a serious complication of systemic glucocorticoid use. However, while
glucocorticoids increase bone resorption in vitro and in vivo, the mechanism (s) of this effect …

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors

F Arai, T Miyamoto, O Ohneda, T Inada… - The Journal of …, 1999 - rupress.org
Osteoclasts are terminally differentiated cells derived from hematopoietic stem cells.
However, how their precursor cells diverge from macrophagic lineages is not known. We …

Mechanisms of TNF-α–and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

CT Ritchlin, SA Haas-Smith, P Li… - The Journal of …, 2003 - Am Soc Clin Investig
Psoriatic arthritis (PsA) is an inflammatory joint disease characterized by extensive bone
resorption. The mechanisms underlying this matrix loss have not been elucidated. We report …

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

LC Hofbauer, AE Heufelder - Journal of molecular medicine, 2001 - Springer
Receptor activator of nuclear factor (NF-κB) ligand (RANKL), its cellular receptor, receptor
activator of NF-κB (RANK), and the decoy receptor osteoprotegerin (OPG) constitute a novel …